These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 5298445)

  • 1. Inhibition of thromboplastic activity by Trasylol. In vitro investigations concerning the mechanism of inhibition.
    Amris CJ; Hilden M
    Scand J Haematol; 1967; 4(1):3-10. PubMed ID: 5298445
    [No Abstract]   [Full Text] [Related]  

  • 2. Experimental investigations on the antithromboplastic and antifibrinolytic activity of Trasylol.
    Nordström S; Blombäck B; Blombäck M; Olsson P; Zetterqvist E
    Ann N Y Acad Sci; 1968 Jun; 146(2):701-14. PubMed ID: 5305815
    [No Abstract]   [Full Text] [Related]  

  • 3. Inhibition of the activation of Hageman factor (factor XII) by aprotinin (Trasylol).
    Laurel MT; Ratnoff OD; Everson B
    J Lab Clin Med; 1992 May; 119(5):580-5. PubMed ID: 1374787
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Inhibition of the thromboplastic activity of amniotic fluid with Trasylol].
    Slunsky R
    Gynakol Rundsch; 1973; 13(2):147-52. PubMed ID: 4542664
    [No Abstract]   [Full Text] [Related]  

  • 5. Experimental investigations with proteinase inhibitors.
    Nordström S; Blombäck M; Olsson P; Zetterqvist E
    Acta Chir Scand Suppl; 1967; 378():33-40. PubMed ID: 5300105
    [No Abstract]   [Full Text] [Related]  

  • 6. [Inhibition of the thromboplastic effect of placental extracts using trasylol].
    Slunsky R
    Z Geburtshilfe Perinatol; 1972 Jun; 176(3):201-6. PubMed ID: 4538438
    [No Abstract]   [Full Text] [Related]  

  • 7. The effect of Trasylol on blood coagulation after intravenous injection.
    Gormsen J; Josephsen P
    Thromb Diath Haemorrh; 1967 Feb; 17(1-2):51-7. PubMed ID: 5300648
    [No Abstract]   [Full Text] [Related]  

  • 8. Effects of epsilon aminocaproic acid (EACA) and Trasylol on thromboplastin-induced intravascular coagulation, studied in dogs with iodine-labelled fibrinogen.
    Nordstrm S; Zetterqvist E
    Acta Physiol Scand; 1969; 76(1):93-105. PubMed ID: 5307271
    [No Abstract]   [Full Text] [Related]  

  • 9. Effect of Trasylol on thromboplastin-induced arterial hypotension.
    Nordström S
    Acta Physiol Scand; 1970 Aug; 79(4):469-74. PubMed ID: 5312074
    [No Abstract]   [Full Text] [Related]  

  • 10. [Trasylol as inhibitor of the thromboplastic effect of amniotic fluid and placental extracts].
    Slunsky R
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1972; 98(3):338-45. PubMed ID: 4123098
    [No Abstract]   [Full Text] [Related]  

  • 11. Tissue factor-induced coagulation can be inhibited by aprotinin (Trasylol).
    van den Besselaar AM; Dirven R; Bertina RM
    Thromb Haemost; 1993 Mar; 69(3):298-9. PubMed ID: 7682341
    [No Abstract]   [Full Text] [Related]  

  • 12. Anticoagulant effects of Trasylol: in vitro and in vivo studies.
    Amris CJ; Hilden M
    Ann N Y Acad Sci; 1968 Jun; 146(2):612-24. PubMed ID: 5306290
    [No Abstract]   [Full Text] [Related]  

  • 13. Inhibition of thromboplastin-induced intravascular coagulation by heparin and Trasylol.
    Nordström S
    Acta Physiol Scand; 1970 Jul; 79(3):390-404. PubMed ID: 5311148
    [No Abstract]   [Full Text] [Related]  

  • 14. Studies on the anticoagulant action of aprotinin ("trasylol").
    Prentice CR; Mcnicol GP; Macnicol GP; Douglas AS
    Thromb Diath Haemorrh; 1970 Oct; 24(1):265-72. PubMed ID: 5312434
    [No Abstract]   [Full Text] [Related]  

  • 15. Effect of Trasylol on fibrin deposition and elimination in the lungs of rats with intravascular coagulation induced by thrombin or thromboplastin.
    Diffang C; Saldeen T
    Thromb Res; 1974 Sep; 5(3):263-76. PubMed ID: 4548231
    [No Abstract]   [Full Text] [Related]  

  • 16. [Mechanism of the occurrence of blood noncoagulability on the entrance into the blood stream of substances with thromboplastin activity].
    Oĭvin IA; Baluda VP
    Probl Gematol Pereliv Krovi; 1972 Apr; 17(4):23-8. PubMed ID: 4680850
    [No Abstract]   [Full Text] [Related]  

  • 17. Disappearance of ellagic acid induced hyper-coagulability in the dog after trasylol administration.
    Girolami A; Brunetti A; Cella G; Pedrazzoli S; Bernardi R
    Thromb Diath Haemorrh; 1973 May; 29(2):384-92. PubMed ID: 4543444
    [No Abstract]   [Full Text] [Related]  

  • 18. Hemoglobin, inhibitor of the contact phase of blood coagulation.
    Triantaphyllopoulos E
    Life Sci II; 1971 Jul; 10(14):813-22. PubMed ID: 5565655
    [No Abstract]   [Full Text] [Related]  

  • 19. Inhibition of fibrinolytic and thromboplastic activity by Trasylol.
    Amris CJ
    Scand J Haematol; 1966; 3(1):19-32. PubMed ID: 4223779
    [No Abstract]   [Full Text] [Related]  

  • 20. Effects of fibrinolytic inhibitors and heparin on induced intravascular coagulation.
    Nordström S
    Acta Physiol Scand Suppl; 1970; 337():1-35. PubMed ID: 5311663
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.